nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclizine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.147	0.174	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.04	0.0474	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0392	0.0465	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0336	0.0399	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.033	0.0391	CbGpPWpGaD
Meclizine—Azelastine—HRH3—attention deficit hyperactivity disorder	0.0285	0.182	CrCbGaD
Meclizine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0238	0.0282	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0228	0.0271	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0221	0.0262	CbGpPWpGaD
Meclizine—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.0219	0.0259	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0214	0.0254	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.021	0.0249	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0208	0.0246	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.02	0.0237	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0193	0.0229	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0186	0.022	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.018	0.0213	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0177	0.0209	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0175	0.0207	CbGpPWpGaD
Meclizine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0163	0.0193	CbGpPWpGaD
Meclizine—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.016	0.102	CrCbGaD
Meclizine—Cinnarizine—CACNA1C—attention deficit hyperactivity disorder	0.0148	0.0947	CrCbGaD
Meclizine—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0137	0.0162	CbGpPWpGaD
Meclizine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0135	0.0161	CbGpPWpGaD
Meclizine—Fluspirilene—ADRA2A—attention deficit hyperactivity disorder	0.0134	0.0857	CrCbGaD
Meclizine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0114	0.0135	CbGpPWpGaD
Meclizine—Fluspirilene—SLC6A4—attention deficit hyperactivity disorder	0.0102	0.0654	CrCbGaD
Meclizine—Fluspirilene—DRD2—attention deficit hyperactivity disorder	0.0102	0.065	CrCbGaD
Meclizine—Nefazodone—SLC6A3—attention deficit hyperactivity disorder	0.0102	0.065	CrCbGaD
Meclizine—Nefazodone—ADRA2A—attention deficit hyperactivity disorder	0.00996	0.0637	CrCbGaD
Meclizine—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00927	0.011	CbGpPWpGaD
Meclizine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00905	0.0579	CrCbGaD
Meclizine—Fluspirilene—HTR2A—attention deficit hyperactivity disorder	0.00786	0.0503	CrCbGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00772	0.00915	CbGpPWpGaD
Meclizine—Nefazodone—SLC6A4—attention deficit hyperactivity disorder	0.0076	0.0486	CrCbGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00757	0.00897	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00751	0.0089	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00662	0.00784	CbGpPWpGaD
Meclizine—Cinnarizine—DRD2—attention deficit hyperactivity disorder	0.00652	0.0417	CrCbGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00648	0.00768	CbGpPWpGaD
Meclizine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.00626	0.0401	CrCbGaD
Meclizine—Nefazodone—HTR2A—attention deficit hyperactivity disorder	0.00584	0.0374	CrCbGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00524	0.00622	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00504	0.00597	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00494	0.00585	CbGpPWpGaD
Meclizine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00484	0.00574	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00458	0.00543	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00449	0.00533	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00426	0.00505	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00425	0.00503	CbGpPWpGaD
Meclizine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0042	0.00498	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00413	0.00489	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00406	0.00481	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00401	0.00475	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00393	0.00466	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00386	0.00457	CbGpPWpGaD
Meclizine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00384	0.00456	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00373	0.00442	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00365	0.00433	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00354	0.00419	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00348	0.00412	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00343	0.00407	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00342	0.00406	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00338	0.00401	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0032	0.00379	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00302	0.00359	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00299	0.00354	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00285	0.00338	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00279	0.00331	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00278	0.0033	CbGpPWpGaD
Meclizine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00277	0.00328	CbGpPWpGaD
Meclizine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00277	0.00328	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00269	0.00319	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00265	0.00314	CbGpPWpGaD
Meclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00261	0.0031	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00261	0.0031	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00259	0.00306	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00253	0.003	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00244	0.00289	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00228	0.0027	CbGpPWpGaD
Meclizine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00225	0.00266	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00224	0.00265	CbGpPWpGaD
Meclizine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00223	0.00265	CbGpPWpGaD
Meclizine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00222	0.00263	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00193	0.00229	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00178	0.00211	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00176	0.00208	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00171	0.00202	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00169	0.002	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00157	0.00186	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00153	0.00182	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00153	0.00181	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00152	0.0018	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0015	0.00177	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0015	0.00177	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00148	0.00175	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00147	0.00174	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00143	0.00169	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00138	0.00164	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00138	0.00163	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00136	0.00161	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00134	0.00159	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00125	0.00148	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00104	0.00123	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000964	0.00114	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000919	0.00109	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000907	0.00107	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000875	0.00104	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000843	0.000999	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000816	0.000968	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000802	0.000951	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000792	0.000939	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000738	0.000875	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000635	0.000752	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000635	0.000752	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000624	0.00074	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00058	0.000688	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000517	0.000613	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000507	0.000601	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000483	0.000572	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000384	0.000456	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000382	0.000453	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00037	0.000439	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000274	0.000325	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000165	0.000195	CbGpPWpGaD
